Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2024 08:00 ET | Source: Checkpoint Therapeutics, Inc

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN, South Korea and WALTHAM,...